Acurx Pharmaceuticals Inc (NASDAQ:ACXP)
| 3.53 Delayed Data As of Nov 30 |  -0.06 / -1.68%Today’s Change | 1.17 Today|||52-Week Range 8.82 | -11.31% Year-to-Date |
Latest ACXP News | Press Releases
No recent news for Acurx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 3.58 |
| Today’s open | 3.60 |
| Day’s range | 3.52 - 3.70 |
| Volume | 68,510 |
| Average volume (3 months) | 549,339 |
| Market cap | -- |
Data as of 3:59pm ET, 11/30/2023
Growth & Valuation
| Earnings growth (last year) | +10.40% |
| Earnings growth (this year) | +26.19% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | March 14, 2024 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
